Trial Profile
Adjunctive Lisdexamfetamine in Bipolar Depression
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 04 Sep 2015
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Bipolar disorders
- Focus Registrational; Therapeutic Use
- 28 Mar 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 29 Oct 2012 Planned End Date changed from 1 Dec 2012 to 1 Dec 2013 as reported by ClinicalTrials.gov.
- 21 Jun 2011 Additional lead trial centre identified as reported by ClinicalTrials.gov.